Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
$CHWY Chewy momentum keeps building as the pet care industry booms, with rising pet adoption and aging pet populations driving demand. BofA Securities maintained its Buy rating on Chewy, holding a price target of $49, seeing the company well-positioned to capture over $1 billion in additional revenue. With smart moves in logistics and a loyal customer base, Chewy is set to ride this wave of market growth while expanding its share in the rapidly growing pet care market.
$GTLB GitLab has caught the eye of Piper Sandler, which initiated coverage with an Overweight rating and a price target of $15. As developers continue shifting towards CI/CD platforms, GitLab’s integrated DevSecOps approach positions it to capture more enterprise demand. This upgrade signals confidence in GitLab’s ability to expand its market share while the company continues to optimize its path toward profitability.
$HQY HealthEquity earned a Relative Strength Rating upgrade as its price performance continues to improve, reflecting growing confidence in its financial positioning. HealthEquity benefits from rising adoption of Health Savings Accounts, a trend that may accelerate if interest rates remain higher for longer. This RS upgrade suggests that HealthEquity momentum could continue, with its disciplined management and expanding customer base underpinning growth.
$NTNX Goldman Sachs initiated Nutanix with a Buy rating after the stock climbed 20% in 2025, underscoring confidence in its hybrid cloud platform strategy. Nutanix’s move towards subscription-based models has stabilized revenue streams and strengthened customer retention. As enterprises continue adopting multi-cloud strategies, Nutanix’s software-defined solutions could keep driving share gains in a competitive environment.
$OTIS Otis Worldwide secured an upgrade from JP Morgan, moving from Neutral to Overweight with a price target increase from $101 to $109. This follows a pullback that now looks like an opportunity for value-focused investors. Otis’s stable near-term outlook, combined with resilient demand for maintenance services and new installations, supports a case for upside in the quarters ahead.
Yesterday at 08:39
Yesterday at 01:17
July 14, 2025 08:30 PM
July 14, 2025 08:04 PM
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Yesterday at 08:39
Yesterday at 01:17
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.